Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Vaccines01:30

Cancer Vaccines

960
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
960

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

PROTEUS Trial the Day After: Practice Changing or Premature Escalation?

European urology oncology·2026
Same author

Reirradiation for recurrent head and neck squamous cell carcinoma: international expert consensus recommendations endorsed by the Reirradiation Collaborative Group, the European Society for Radiotherapy and Oncology Reirradiation Focus Group, and the American Society for Radiation Oncology.

The Lancet. Oncology·2026
Same author

Standardization of objectives and response criteria for neoadjuvant immunotherapy in resectable squamous cell carcinoma of the head and neck.

Cancer treatment reviews·2026
Same author

Defining physician acceptance of radiosensitivity testing for guiding therapeutic interventions in head and neck cancer: A Delphi consensus study.

Clinical and translational radiation oncology·2026
Same author

Re-evaluating Biochemical Recurrence Definitions After Radiation Therapy: Time to Move Beyond "Phoenix"?

International journal of radiation oncology, biology, physics·2026
Same author

Tumor immune microenvironment predicts recurrence after radiotherapy in oropharyngeal squamous cell carcinoma.

Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology·2026
Same journal

White paper on radiotherapy in France: Ten objectives to strengthen one of the major modalities of cancer treatment.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Contemporary survival outcomes of patients with isolated nodal recurrences of breast cancer: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Factors affecting the stability of deep inspiration breath-holding in radiotherapy for left-sided breast cancers.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Incidence and outcomes of radiation-induced sarcomas following radiotherapy for low-grade non-Hodgkin lymphomas: A population-based study.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Radiotherapy as a curative strategy for primary pleural indolent lymphomas: Analytical guidelines based on literature and an illustrative population-based case series.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
Same journal

Cone-beam computed tomography-based radiomics for tumour regression assessment during radiotherapy of non-small-cell lung cancer.

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2026
See all related articles

Related Experiment Video

Updated: Jan 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K

Radiotherapy for hypopharynx cancers: 2025 update.

Dylan Bocha1, Julian Biau2, Alexandre Coutte3

  • 1Département de radiothérapie, Sainte-Catherine Institut du cancer Avignon-Provence, 250, chemin de Baigne-Pieds, 84918 Avignon, France.

Cancer Radiotherapie : Journal De La Societe Francaise De Radiotherapie Oncologique
|October 15, 2025
PubMed
Summary
This summary is machine-generated.

Updated French guidelines recommend intensity-modulated radiotherapy as the standard for hypopharynx cancer. Treatment varies by stage, including surgery, radiation, or chemoradiation, with specific dose recommendations for curative and prophylactic radiotherapy.

Keywords:
CancerDelineationDoseHypopharynxHypopharynx cancerIndicationIntensity-modulated radiotherapyModulation d’intensitéRadiothérapieRecommandationRecommendationSFROSociété française de radiothérapie oncologique

More Related Videos

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.2K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K

Related Experiment Videos

Last Updated: Jan 15, 2026

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.9K
Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma
06:11

Therapy Testing in a Spheroid-based 3D Cell Culture Model for Head and Neck Squamous Cell Carcinoma

Published on: April 20, 2018

10.2K
Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy
08:17

Dynamic Lung Tumor Tracking for Stereotactic Ablative Body Radiation Therapy

Published on: June 7, 2015

16.2K

Area of Science:

  • Oncology
  • Radiotherapy
  • Head and Neck Cancer

Background:

  • Hypopharynx cancer treatment requires updated recommendations.
  • Intensity-modulated radiotherapy (IMRT) is the established standard.

Purpose of the Study:

  • To present the updated French Society of Radiation Oncology guidelines for hypopharynx cancer radiotherapy.
  • To outline treatment strategies based on tumor stage and characteristics.

Main Methods:

  • Review and update of existing radiotherapy guidelines for hypopharynx cancer.
  • Inclusion of recommendations for early-stage, locally advanced, and T4 tumors.
  • Specification of fractionation schedules and dose prescriptions for curative and prophylactic radiotherapy.
  • Consideration of postoperative radiotherapy based on pathological criteria.

Main Results:

  • IMRT is the gold standard for hypopharynx cancers.
  • Early T1/T2 tumors: exclusive radiation or surgery followed by radiation.
  • Locally advanced T2/T3 tumors: chemoradiation or induction chemotherapy followed by radiation.
  • T4 tumors: surgery is recommended.
  • Specific curative and prophylactic radiation doses and fractionation schedules are detailed.
  • Postoperative radiotherapy doses depend on pathological findings (e.g., R1 resection, extracapsular spread).

Conclusions:

  • The guidelines provide a comprehensive framework for radiotherapy in hypopharynx cancer.
  • Treatment decisions are stage-dependent, integrating surgery, radiation, and chemotherapy.
  • Dose fractionation and prescription are critical for efficacy and toxicity, particularly regarding larynx toxicity.